Carina Ittrich
Overview
Explore the profile of Carina Ittrich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
911
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gisli Jenkins R, Cottin V, Nishioka Y, Noth I, White E, Ittrich C, et al.
ERJ Open Res
. 2024 Dec;
10(6).
PMID: 39687396
Background: Biomarkers that change in response to nintedanib in subjects with idiopathic pulmonary fibrosis (IPF) would be valuable. We investigated the effects of nintedanib on circulating biomarkers in subjects with...
2.
Maher T, Gisli Jenkins R, Cottin V, Nishioka Y, Noth I, Selman M, et al.
ERJ Open Res
. 2024 Jul;
10(4).
PMID: 39040590
Background: We used data from the INMARK trial to investigate associations between circulating biomarkers of extracellular matrix (ECM) turnover, inflammation and epithelial dysfunction and disease progression in subjects with idiopathic...
3.
Campo I, Meloni F, Gahlemann M, Sauter W, Ittrich C, Schoelch C, et al.
Sci Rep
. 2022 May;
12(1):8708.
PMID: 35610268
Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare lung disorder involving production of autoantibodies against endogenous granulocyte-macrophage colony-stimulating factor (GM-CSF). This study aimed to identify biomarkers that could be used...
4.
Varlet P, Bouffet E, Casanova M, Giangaspero F, Antonelli M, Hargrave D, et al.
Pediatr Blood Cancer
. 2021 Sep;
69(1):e29316.
PMID: 34546642
Background: There is a paucity of knowledge regarding pediatric biomarkers, including the relevance of ErbB pathway aberrations in pediatric tumors. We investigated the occurrence of ErbB receptor aberrations across different...
5.
Crapo J, Gupta A, Lynch D, Vogel-Claussen J, Watz H, Turner A, et al.
BMJ Open
. 2021 Mar;
11(3):e042526.
PMID: 33753437
Introduction: A better understanding is needed of the different phenotypes that exist for patients with chronic obstructive pulmonary disease (COPD), their relationship with the pathogenesis of COPD and how they...
6.
Maher T, Stowasser S, Nishioka Y, White E, Cottin V, Noth I, et al.
Lancet Respir Med
. 2019 Jul;
7(9):771-779.
PMID: 31326319
Background: A hallmark of idiopathic pulmonary fibrosis is the excess accumulation of extracellular matrix in the lungs. Degradation of extracellular matrix generates free-circulating protein fragments called neoepitopes. The aim of...
7.
Schumacher F, Schubert S, Hannus M, Sonnichsen B, Ittrich C, Kreideweiss S, et al.
PLoS One
. 2016 Nov;
11(11):e0166352.
PMID: 27832175
Chronic Obstructive Pulmonary Disease (COPD) is a highly prevalent condition characterized by inflammation and progressive obstruction of the airways. At present, there is no treatment that suppresses the chronic inflammation...
8.
Rast G, Kraushaar U, Buckenmaier S, Ittrich C, Guth B
J Pharmacol Toxicol Methods
. 2016 Aug;
82:74-82.
PMID: 27521052
Introduction: Field potential duration in human pluripotent stem cell (hiPSC)-derived cardiomyocytes is discussed as parameter for the assessment of drug-induced delayed repolarization. In spontaneously beating hiPSC-derived cardiomyocytes field potential duration...
9.
Rast G, Weber J, Disch C, Schuck E, Ittrich C, Guth B
J Pharmacol Toxicol Methods
. 2015 Apr;
75:91-100.
PMID: 25921432
Introduction: Human induced pluripotent stem cell-derived cardiomyocytes are available from various sources and they are being evaluated for safety testing. Several platforms are available offering different assay principles and read-out...
10.
Zimdahl H, Ittrich C, Graefe-Mody U, Boehm B, Mark M, Woerle H, et al.
Diabetologia
. 2014 Jun;
57(9):1869-75.
PMID: 24906949
Aims/hypothesis: Individuals carrying variants of the transcription factor 7-like 2 gene (TCF7L2) are at increased risk for type 2 diabetes. These metabolic genetic risk factors have been linked to diminished...